[1]
“Ex-vivo and in-vivo evaluation of nanostructured lipid carrier loaded with gemcitabine and paclitaxel in A549 lung cell for management of resistant cancers”, Int. J. Pharm. Sci. Drug Res., vol. 13, no. 4, pp. 410–417, Jul. 2021, doi: 10.25004/IJPSDR.2021.130407.